First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab

Case Reports in Cardiology - Egypt
doi 10.1155/2017/6458636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Idarucizumab Resistance Due to a Markedly Elevated Dabigatran Concentration – A Case Report

Pathology
Forensic MedicinePathology
2020English

Dabigatran-Induced Spontaneous Hemopericardium and Cardiac Tamponade

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2017English

First Reported Case Series in the United States of Hemopericardium in Patients on Apixaban

HeartRhythm Case Reports
Cardiovascular MedicineCardiology
2018English

Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report

American Journal of Hematology
Hematology
2017English

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke

Frontiers in Neurology
Neurology
2019English

Idarucizumab Dosing in Patients With Excessive Dabigatran Body Burden

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2019English

Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis

Clinical Pharmacokinetics
Pharmacology
2020English

Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis

Journal of Neurology
Neurology
2017English

Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report

Journal of Medical Case Reports
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy